Lv1
30 积分 2026-10-22 加入
Impact of American Urological Association risk category on outcomes of intravesical BCG vs gemcitabine/docetaxel in high‐grade Ta non‐muscle‐invasive bladder cancer
22小时前
已完结
Phase 2 Trial of Intravesical Gemcitabine and Docetaxel as First-Line Treatment of Bacillus Calmette-Guérin‒Naïve Nonmuscle-Invasive Urothelial Carcinoma: Updated, 3-Year Outcomes
1天前
求助中
皖公网安备34019202002308
